We recently reported that a novel class of compounds (PCAIs), induced a decrease in the levels of RhoA in the NCI-H1299 non-small cell lung cancer cells to disrupt F-actin organization and abrogate cell migration [18]. The gene discussed is RHOA; the disease is non-small cell lung carcinoma.